Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 18
- Q1 2026, −2 vs. previous quarter
- 13F value
- $41.3K
- Reported value at the end of Q1 2026
- Superinvestors holding
- 0
- At the end of Q1 2026
Superinvestors holding ITRM, Q1 2026
No superinvestor reported holding ITRM at the end of Q1 2026.
Latest insider trades
Open-market purchases and sales by Iterum Therapeutics plc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 (view filing)7:00 AM ET | Nov 18 | 2 days | Dunne Michael W.Director | PPurchase | +6.00K | $0.3652 | +$2.19K | +2.6%241.0K after | |
| Aug 12, 2025 (view filing) | Aug 8 | 4 days | Dunne Michael W.Director | PPurchase | +15.0K | $0.72 | +$10.8K | +6.8%235.0K after | |
| Dec 27, 2023 (view filing) | Dec 22 | 5 days | Dunne Michael W.Director | PPurchase | +25.0K | $1.40 | +$35.0K | +28.2%113.8K after | |
| Dec 19, 2023 (view filing) | Dec 18 | 1 day | Dunne Michael W.Director | PPurchase | +10.0K | $1.84 | +$18.4K | +12.7%88.8K after | |
| Nov 27, 2023 (view filing) | Nov 22 | 5 days | Dunne Michael W.Director | PPurchase | +20.0K | $2.03 | +$40.6K | +34.0%78.8K after | |
| Nov 20, 2023 (view filing) | Nov 20 | Same day | Fishman Corey N.Chief Executive Officer | PPurchase | +10.0K | $1.59 | +$15.9K | +22.5%54.4K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Puttagunta SailajaChief Medical Officer | SSale | −3.37K | $1.32 | −$4.44K | −40.4%4.97K after | |
| Sep 20, 2022 (view filing) | Sep 16-20 | 4 days | Ahrens Brenton KarlDirector | SSale | −37.2K | $1.82 | −$67.9K | −100.0%0 after | 3 lots |
| Sep 15, 2022 (view filing) | Sep 13-15 | 2 days | Ahrens Brenton KarlDirector | SSale | −45.0K | $2.09 | −$93.9K | −54.7%37.2K after | 3 lots |
| Sep 12, 2022 (view filing) | Sep 8-12 | 4 days | Ahrens Brenton KarlDirector | SSale | −33.3K | $2.31 | −$76.9K | −28.8%82.2K after | 3 lots |
Top 10 13F holders, Q1 2026
The largest institutional positions in Iterum Therapeutics plc at the end of Q1 2026; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 890,083 | $26.0K | 0.00% | +890,083 | New |
| Captrust Financial Advisors | 138,600 | $4.16K | 0.00% | 00.0% | Unchanged |
| Gen-Wealth Partners Inc | 82,617 | $2.48K | 0.00% | −2,013−2.4% | Reduced |
| Jump Financial, LLC | 72,156 | $2.17K | 0.00% | +72,156 | New |
| Krilogy Financial LLC | 69,761 | $1.74K | 0.00% | +29,761+74.4% | Added |
| XTX Topco Ltd | 49,380 | $1.48K | 0.00% | +49,380 | New |
| MAI Capital Management | 35,000 | $1.05K | 0.00% | +35,000 | New |
| SG Americas Securities, LLC | 33,464 | $1.00K | 0.00% | +20,682+161.8% | Added |
| Flagship Harbor Advisors, LLC | 20,000 | $600 | 0.00% | +20,000 | New |
| Morgan Stanley | 15,713 | $471 | 0.00% | +10,000+175.0% | Added |